Journal articleJACC Cardiovasc Interv · July 27, 2026
BACKGROUND: The optimal antithrombotic strategy after valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) for degenerated aortic bioprostheses remains undetermined, and current practice patterns in the United States are not well characterize ...
Full textLink to itemCite
Journal articleStruct Heart · May 2026
BACKGROUND: Functional mitral regurgitation (FMR) is associated with poor heart failure (HF) outcomes. Mitral transcatheter edge-to-edge repair (M-TEER) is recommended for symptomatic patients despite medical therapy, though the influence of sex and race o ...
Full textLink to itemCite